Search

Biological Scientist II: bacteriology and virology research, including phage work.

CDC has some AMAZING new interactive visualizations for Antibiotic Resistance by species, geography, and indication. Great for educating people on how big the problem is. Check it out! — Contributed by Natalie Ma via Twitter

In an effort to help companies navigate the development of their bacteriophage product, IHMA’s VP Global Microbiology Services & CSO, Daniel Sahm has compiled a summary of key considerations to address prior to beginning clinical trials.

Thanks to all who came out to the first iVoM Season 2 event of 2022! Next: Feb 2 from 2-3 PM CET Topic: Phage application in the One Health approach. Speakers: Dr. Cath Rees, Prof. Mariana Piuri, Prof. Lone Brøndsted. If you want to join

IPATH invites the phage therapy community to the virtual screening and discussion event for the new documentary, Salt in My Soul. This film recounts the struggles and feelings of Mallory Smith, who lost her battle with cystic fibrosis and a

Paper: Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae. — Anaïs Eskenazi et al

Paper: Lambda phage ‘counts’ the number of coinfecting viruses and then uses this to assess the abundance of potential hosts and decide whether to become dormant. This single-cell tool illuminates how! — Tianyou Yao et al.

Paper: Bacteriostatic antibiotics promote CRISPR-Cas adaptive immunity by enabling increased spacer acquisition — Tatiana Dimitriu et al

Preprint: Multiple phage resistance systems inhibit infection via SIR2-dependent NAD+ depletion — Jeremy Garb et al.

Olivier Zablocki shares an updated ecosystem of microbiome/virome apps and guides (iVirus 2), which are freely available to run on CyVerse & DOE KBase. Learn more with their new perspective piece.

In an effort to help companies navigate the development of their bacteriophage product, IHMA’s VP Global Microbiology Services & CSO, Daniel Sahm has compiled a summary of key considerations to address prior to beginning clinical trials.

A bioreactor should provide the ideal environment for cells (and by extension, phages!). But choosing your setup can be tough. This week, Robert Matthew from Cellexus provides a nice explainer to help you understand your options! The role o

Postdoc in the Anantharaman Lab to develop and apply bioinformatic tools to study ecology, evolution, and diversity of viruses/phage in the environment.

PhD project to study microbiome-based strategies for biocontrol of C. difficile at the Quadram Institute Bioscience, UK.

A 2-year postdoctoral position is available at the Saint-Antoine Research Centre (Sorbonne University, Paris, France) to work on the interactions between bacteriophages, the intestinal mucosa and the epithelial barrier function in acute and

Research Fellowship at the Center of Biological Engineering to work on the R&D project, Phages-on-chip, an integrated phage-based microdevice for multiplex detection of bloodstream infections.

Postdoc at APC Microbiome Ireland to mine biological entities (‘pharmabiotics’) from the gut, including probiotics, prebiotics, bacteriocins, bacteriophages and other bioactive molecules.

Biological or chemical technical assistant at Friedrich Schiller University to work in the new Viral Ecology and Omics group of Prof. Bas E. Dutilh, which aims to study the role of viruses in the Microverse.

The CellMaker is the ultimate phage making machine. With batch-to-batch reproducibility and complete control over the growth environment, the CellMaker gives accurate and reliable results, so you can focus on more important tasks. Find out

Thanks to all who came out to the first iVoM Season 2 event of 2022! Next: Feb 2 from 2-3 PM CET Topic: Phage application in the One Health approach. Speakers: Dr. Cath Rees, Prof. Mariana Piuri, Prof. Lone Brøndsted. If you want to join